C3is (CISS) Registration filing summary

Risk factors and disclosures

• Indemnification provisions protect directors and officers if they act in good faith and in the company's best interests, with limitations for criminal or negligent conduct.

• Insurance may be purchased to cover liabilities for directors and officers, even if indemnification is not available.

• SEC may consider certain indemnification provisions unenforceable as contrary to public policy, requiring court adjudication if claims arise.

Management team and governance

• CEO and principal executive officer is Dr. Diamantis Andriotis, with Harry N. Vafias as CFO and other directors including Nina Pyndiah, John Kostoyannis, and George Xiradakis.

• U.S. authorized representative is Donald J. Puglisi of Puglisi & Associates.

Offering details and pricing

• Registration statement filed for a public offering, with securities potentially offered on a delayed or continuous basis under Rule 415.

• Post-effective amendments will be filed as needed to update or change offering details, including prospectus and financial statements.